[go: up one dir, main page]

AU1646701A - Composition for treating respiratory tract infections - Google Patents

Composition for treating respiratory tract infections

Info

Publication number
AU1646701A
AU1646701A AU16467/01A AU1646701A AU1646701A AU 1646701 A AU1646701 A AU 1646701A AU 16467/01 A AU16467/01 A AU 16467/01A AU 1646701 A AU1646701 A AU 1646701A AU 1646701 A AU1646701 A AU 1646701A
Authority
AU
Australia
Prior art keywords
composition
respiratory tract
tract infections
treating respiratory
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16467/01A
Inventor
Jean Chatillon
Paul Ghislain Coupan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Top Pharm SARL
Original Assignee
Laboratoire Top Pharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Top Pharm SARL filed Critical Laboratoire Top Pharm SARL
Publication of AU1646701A publication Critical patent/AU1646701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU16467/01A 1999-11-10 2000-11-09 Composition for treating respiratory tract infections Abandoned AU1646701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9914102A FR2800614B1 (en) 1999-11-10 1999-11-10 COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
FR9914102 1999-11-10
PCT/FR2000/003114 WO2001034182A2 (en) 1999-11-10 2000-11-09 Composition for treating respiratory tract infections containing menthol, eucalyptol and an alpha-amylase

Publications (1)

Publication Number Publication Date
AU1646701A true AU1646701A (en) 2001-06-06

Family

ID=9551940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16467/01A Abandoned AU1646701A (en) 1999-11-10 2000-11-09 Composition for treating respiratory tract infections

Country Status (3)

Country Link
AU (1) AU1646701A (en)
FR (1) FR2800614B1 (en)
WO (1) WO2001034182A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827776B1 (en) * 2001-07-25 2005-09-30 Top Pharm Lab COMPOSITION COMPRISING AN ENZYMATIC ANTI-INFLAMMATORY AND A MUCOLYTIC
DE102006032233A1 (en) * 2006-07-12 2008-01-17 Ewabo Chemikalien Gmbh & Co. Kg Use of a preparation containing eucalyptol/menthol for the production of medicament for combating and preventing virus infection and secondary bacterial infection
FR2927256B1 (en) * 2008-02-13 2010-05-14 Top Pharm Lab COMPOSITION FOR THE TREATMENT OF ALFA-AMYLASE RESPIRATORY TRACT INFLAMMATORY DISEASES AND LOCAL ANESTHETICS AND METHOD OF PREPARING THE SAME
WO2010078392A2 (en) * 2008-12-31 2010-07-08 Novozymes North America, Inc. Processes of producing fermentation products
WO2019175783A1 (en) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprising bacterial strains and use thereof in controlling pathogenic microorganisms
US12121649B2 (en) 2018-03-12 2024-10-22 Ecological Balancing Technologies Corporation Cartridge for an automated aerosol dispensing device
WO2019175780A1 (en) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprising bacterial strains and use thereof in controlling pathogenic microorganisms
US12064778B2 (en) 2018-03-12 2024-08-20 Ecological Balancing Technologies Corporation Electronic safety feature for an automated aerosol dispensing device
WO2019175782A1 (en) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprising bacterial strains and use thereof in controlling pathogenic microorganisms
WO2019175777A1 (en) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprising bacterial strains and use thereof in controlling pathogenic microorganisms
US12016513B2 (en) 2018-05-21 2024-06-25 Ecological Balancing Technologies Corporation Automated device and method for spreading environmental friendly microbes on a surface

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740368A (en) * 1985-12-11 1988-04-26 Plevy Donald J Amylase containing breath cleansing confection

Also Published As

Publication number Publication date
FR2800614A1 (en) 2001-05-11
WO2001034182A3 (en) 2002-04-04
FR2800614B1 (en) 2002-01-04
WO2001034182A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
AU7085900A (en) Airway treatment apparatus
AU2001253265A1 (en) Oral treatment systems
AU7859800A (en) Topical nasal treatment
GB0125222D0 (en) Composition for the treatment of microbial infections
AU6908500A (en) Treatment for narcolepsy
AUPQ466999A0 (en) Anaesthetic apparatus
AU6427499A (en) Mouthpiece for breathing devices
AU2000276362A1 (en) Composition for the treatment of diabetes
AU1986099A (en) Device for inhaling medicament
AU1887401A (en) Medicinal composition
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
IL159585A0 (en) Single dose azithromycin for treating respiratory infections
AU1646701A (en) Composition for treating respiratory tract infections
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU5029700A (en) Glycopeptide antibacterial compounds, compositions containing same and methods of using same
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU2021601A (en) Composition for the treatment of dandruff
AU2263801A (en) Quinolone compounds for use in treating viral infections
AU2002364679A1 (en) Method and compositions for treating respiratory pathologies
AU4145999A (en) Topical drug for the treatment of viral infections
AU2000231423A1 (en) Specific therapeutic composition for treating aids
AU5245600A (en) Medicinal compositions for treating lower uropathy
AU1039601A (en) Medicaments for treatment of respiratory syncytial virus infections
AU1673200A (en) Medicaments for the treatment of lung infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase